Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 19 articles:
HTML format
Text format



Single Articles


    September 2017
  1. FUSI F, Durante M, Gorelli B, Perrone MG, et al
    MC225, a novel probe for P-glycoprotein PET Imaging at the blood-brain barrier: in vitro cardiovascular safety evaluation.
    J Cardiovasc Pharmacol. 2017 Sep 1. doi: 10.1097/FJC.0000000000000536.
    PubMed     Text format     Abstract available


    August 2017
  2. AUDET N, Dabouz R, Allen BG, Hebert TE, et al
    Nucleoligands- repurposing GPCR ligands to modulate nuclear-localized GPCRs in the cardiovascular system.
    J Cardiovasc Pharmacol. 2017 Aug 29. doi: 10.1097/FJC.0000000000000535.
    PubMed     Text format     Abstract available


  3. LIU ZY, Hu S, Zhong QW, Tian CN, et al
    N-Methyl-D-Aspartate Receptor (NMDAR)-Driven Calcium Influx Potentiates the Adverse Effects of Myocardial Ischemia-Reperfusion Injury Ex Vivo.
    J Cardiovasc Pharmacol. 2017 Aug 4. doi: 10.1097/FJC.0000000000000527.
    PubMed     Text format     Abstract available


    July 2017
  4. KLJUCEVIC N, Milat AM, Grga M, Mudnic I, et al
    White wine consumption influences inflammatory phase of repair following myocardial infarction in rats.
    J Cardiovasc Pharmacol. 2017 Jul 19. doi: 10.1097/FJC.0000000000000519.
    PubMed     Text format     Abstract available


  5. CAO S, Zhou Q, Chen JL, Cui JJ, et al
    Comparison of Intracoronary and Intravenous Ultrasound-targeted Microbubble Destruction-mediated Ang1 Gene Transfection on Left Ventricular Remodeling in Canines With Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017;70:25-33.
    PubMed     Text format     Abstract available


    April 2017
  6. SERVILLO L, D'Onofrio N, Balestrieri ML
    Ergothioneine Antioxidant Function: From Chemistry to Cardiovascular Therapeutic Potential.
    J Cardiovasc Pharmacol. 2017;69:183-191.
    PubMed     Text format     Abstract available


    March 2017
  7. SCHUMACHER SM, Koch WJ
    Non-canonical roles of GRKs in cardiovascular signaling.
    J Cardiovasc Pharmacol. 2017 Mar 17. doi: 10.1097/FJC.0000000000000483.
    PubMed     Text format     Abstract available


  8. MAURO AG, Mezzaroma E, Torrado J, Kundur P, et al
    Reduction of Myocardial Ischemia-Reperfusion Injury by Inhibiting Interleukin-1 Alpha.
    J Cardiovasc Pharmacol. 2017;69:156-160.
    PubMed     Text format     Abstract available


    February 2017
  9. MAURO AG, Mezzaroma E, Marchetti C, Narayan P, et al
    A Preclinical Translational Study Of The Cardioprotective Effects Of Plasma Derived Alpha-1 Anti-Trypsin In Acute Myocardial Infarction.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000474.
    PubMed     Text format     Abstract available


  10. BORGHI C, Omboni S, Novo S, Vinereanu D, et al
    Early Treatment With Zofenopril And Ramipril In Combination With Acetyl Salicylic Acid In Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: Results Of A 5-Year Follow-Up Of Patients Of The Smile-4 Study.
    J Cardiovasc Pharmacol. 2017 Feb 13. doi: 10.1097/FJC.0000000000000473.
    PubMed     Text format     Abstract available


    January 2017
  11. SUN J, Xiang Q, Li C, Wang Z, et al
    Efficacy and safety of novel oral P2Y12 receptor inhibitors in ST-segment elevation myocardial infarction patients undergoing PCI: A systematic review and meta-analysis.
    J Cardiovasc Pharmacol. 2017 Jan 3. doi: 10.1097/FJC.0000000000000459.
    PubMed     Text format     Abstract available


    December 2016
  12. KAPLAN A, Altara R, Eid A, Booz GW, et al
    Update on the Protective Role of Regulatory T Cells in Myocardial Infarction: A Promising Therapy to Repair the Heart.
    J Cardiovasc Pharmacol. 2016;68:401-413.
    PubMed     Text format     Abstract available


    November 2016
  13. ZHANG L, Lu J, Dong W, Tian H, et al
    Meta-Analysis of Comparison of the Newer P2Y12 Inhibitors (Oral Preparation or Intravenous) to Clopidogrel in Patients with Acute Coronary Syndrome.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    October 2016
  14. BORGHI C, Omboni S, Reggiardo G, Bacchelli S, et al
    Efficacy Of Zofenopril Compared To Placebo And Other Ace-Inhibitors In Patients With Acute Myocardial Infarction And Previous Cardiovascular Risk Factors: A Pooled Individual Data Analysis Of Four Randomized, Double-Blind, Controlled, Prospective Stud
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


  15. SEPARHAM A, Ghaffari S, Najafi H, Ghaffari R, et al
    The Impact of Allopurinol on Patients With Acute ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy.
    J Cardiovasc Pharmacol. 2016;68:265-268.
    PubMed     Text format     Abstract available


    September 2016
  16. WANG C, Li Y, Yang X, Bi S, et al
    Tetramethylpyrazine and astragaloside IV synergistically ameliorate left ventricular remodeling and preserve cardiac function in a rat myocardial infarction model.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  17. MA F, Li T, Zhang H, Wu G, et al
    MiR-30s Family inhibit the Proliferation and Apoptosis in Human Coronary Artery Endothelial Cells through Targeting the 3'UTR Region of ITGA4 and PLCG1.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  18. YANG Q, Wang HC, Liu Y, Gao C, et al
    Resveratrol cardioprotection against myocardial ischemia/reperfusion injury involves upregulation of adiponectin levels and multimerization in type 2 diabetic mice.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  19. CASCON-PEREZ JD, Abellan-Huerta J, Giner-Caro JA, Dau-Villareal DF, et al
    Effectiveness and safety of bivalirudin during percutaneous coronary intervention in acute coronary syndrome in the real world. CARTAGOMAX study.
    J Cardiovasc Pharmacol. 2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: